#5 - DexCom (NASDAQ:DXCM)
Some parts of the internet of things may feel superfluous. Yes, it’s the role of technology to provide solutions that make our life easier. However, at times, it gives us solutions for problems we never really needed to be solved. DexCom (NASDAQ:DXCM) is in the former category and was an easy choice for this list.
What you need to know about DexCom is that they operate in a distinct niche. However, it’s a niche that has a large addressable market. The company provides a glucose monitoring app for diabetics.
One of the daily challenges that diabetics face is the need to monitor their blood sugar. This is typically done by pricking their finger, sometimes as many as seven times a day. DexCom’s app-based tool automatically monitors blood sugar levels with no fingersticks. The system uses an implantable sensor that connects to a smartphone or watch. This allows users to check their levels at any moment.
DXCM stock is up 28% in the last 12 months with analysts giving the stock a nearly 20% upside in the next 12 months.
About DexCom
DexCom, Inc, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions.
Read More - Current Price
- $70.48
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 12 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $104.59 (48.4% Upside)
